Capromorelin Tartrate is a synthetic growth hormone-releasing peptide used in veterinary medicine to manage weight loss, cachexia, and wasting diseases in cats and dogs by stimulating the secretion of… Read more
Capromorelin Tartrate is a synthetic growth hormone-releasing peptide used in veterinary medicine to manage weight loss, cachexia, and wasting diseases in cats and dogs by stimulating the secretion of endogenous growth hormone. As a potent GHRH analog that functions through binding to somatotropic receptors, this compound requires rigorous quality control and analytical oversight during pharmaceutical development. This category provides access to high-quality reference standards of Capromorelin Tartrate, along with its related impurities and metabolites, which are essential for precise impurity profiling and the validation of analytical methods. Furthermore, the inclusion of stable isotope-labelled compounds, such as the deuterated internal standard Capromorelin-d5, facilitates accurate quantitation in bioanalytical studies and pharmacokinetics research. Laboratories utilize these reference materials to ensure compliance with regulatory standards and to maintain the integrity of their analytical testing protocols across drug development and stability assessments.